T-cell Leukemia
10 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma (NCT04840875) | Beijing Boren Hospital | 2021-09-14 |
| Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies (NCT04264078) | Xinqiao Hospital of Chongqing | 2021-03-01 |
| CD4CAR for CD4+ Leukemia and Lymphoma (NCT03829540) | Huda Salman | 2020-07-09 |
| Observatory of Prolymphocytic Leukemia T (NCT04411043) | French Innovative Leukemia Organisation | 2020-07-01 |
| Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) (NCT03792256) | Children's Oncology Group | 2019-04-11 |
| A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) (NCT00611208) | Virogen Biotechnology Inc. | 2008-01-01 |
| Anti-Tac for Treatment of Leukemia (NCT00001941) | National Cancer Institute (NCI) | 1999-12-01 |
Track T-cell Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.